[Editor's note: The complete edited transcript of the Aug. 11 webinar featuring Dr. Jeffrey Moses, Dr. Robert Byrne, Dr. Elizabeth Holper and Dr. Michael Rinaldi is available here. Medtech Insight also conducted a follow-up interview with Byrne.]
Abbott Laboratories Inc.'s Absorb GT1 Bioresorbable Vascular Scaffold (BVS) is a promising technology, but it presents several unique challenges...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?